oramorph 10 mg/5 ml oralni rastvor
inpharm co. d.o.o. banja luka - morfij - oralni rastvor - 10 mg/5 ml - 5 ml oralnog rastvora sadrži: 10 mg morfinsulfata
dexamethasonneomycin galenika 1 mg/1 ml+ 3.5 mg/1 ml kapi za uši/oči, rastvor
galenika d.o.o. - дексаметазон, neomicin - kapi za uši/oči, rastvor - 1 mg/1 ml+ 3.5 mg/1 ml - 1 ml kapi za uši/oči, rastvora sadrži 1,0 mg deksametazon fosfata (u obliku deksametazonnatrijum fosfata) + 3,5 mg neomicina (u obliku neomicinsulfata)
enbecin 3300 i.j./1 g+ 500 i.j./1 g mast za oči
galenika d.o.o. - бацитрацин, neomicin - mast za oči - 3300 i.j./1 g+ 500 i.j./1 g - 1 g masti za oči sadrži: neomicin (u obliku neomicinsulfata) 3300 i.j. bacitracin 500 i.j.
oramorph 2 mg/ml oralna otopina
l. molteni & c. dei f.lli alitti societa di esercizio s.p.a., strada statale 67, fraz. granatieri, scandicci, firenza, italija - morfinsulfat - oralna otopina - 2 mg/ml - urbroj: 1 ml otopine sadrži 2 mg morfinsulfata
oramorph 20 mg/ml oralne kapi, otopina
l. molteni & c. dei f.lli alitti societa di esercizio s.p.a., strada statale 67, fraz. granatieri, scandicci, firenza, italija - morfinsulfat - oralne kapi, otopina - 20 mg/ml - urbroj: 1 ml otopine sadrži 20 mg morfinsulfata
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastična sredstva - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
oramorph 20 mg/1 ml oralne kapi, rastvor
inpharm co. d.o.o. banja luka - morfij - oralne kapi, rastvor - 20 mg/1 ml - 1 ml oralnih kapi, rastvora sadrži: 20 mg morfinsulfata
dexamethasonneomycin galenika 1 mg/1 ml+ 3.5 mg/1 ml kapi za uši/oči, rastvor
galenika d.o.o. - дексаметазон, neomicin - kapi za uši/oči, rastvor - 1 mg/1 ml+ 3.5 mg/1 ml - 1 ml kapi za uši/oči, rastvora sadrži 1,0 mg deksametazon fosfata (u obliku deksametazonnatrijum fosfata) + 3,5 mg neomicina (u obliku neomicinsulfata)
sinoderm n 0.25 mg/1 g+ 3.3 mg/1 g mast
galenika d.o.o. - fluocinolon acetonid, neomicin - mast - 0.25 mg/1 g+ 3.3 mg/1 g - 1 g masti sadrži: 0,25 mg fluocinolon acetonida i 3,30 mg neomicina (u obliku neomicinsulfata)
enbecin 3300 i.j./1 g+ 500 i.j./1 g mast za oči
galenika d.o.o. - бацитрацин, neomicin - mast za oči - 3300 i.j./1 g+ 500 i.j./1 g - 1 g masti za oči sadrži: 3300 i.j. neomicina (u obliku neomicinsulfata) i 500 i.j. bacitracina